Etanercept or infliximab: the patient's considerations.
作者信息
Sherrick Robert C
出版信息
Arch Intern Med. 2006 Jul 10;166(13):1418; author reply 1418. doi: 10.1001/archinte.166.13.1418-a.
Abstract
摘要
相似文献
1
Etanercept or infliximab: the patient's considerations.依那西普或英夫利昔单抗：患者的考量因素。
Arch Intern Med. 2006 Jul 10;166(13):1418; author reply 1418. doi: 10.1001/archinte.166.13.1418-a.
2
Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior.医疗保险对肿瘤坏死因子α抑制剂的覆盖范围对医生处方行为的影响。
Arch Intern Med. 2006 Jan 9;166(1):57-63. doi: 10.1001/archinte.166.1.57.
3
Effective coverage and reimbursement strategies for etanercept and infliximab in the treatment of rheumatoid arthritis.依那西普和英夫利昔单抗治疗类风湿关节炎的有效覆盖范围及报销策略。
Manag Care Interface. 2005 Apr;18(4):32-7.
4
[Anti-rheumatoid biologics and pharmacoeconomic evaluation].[抗类风湿生物制剂与药物经济学评估]
Nihon Rinsho. 2005 Jan;63 Suppl 1:711-8.
5
Anti-tumour necrosis factor therapy in the West Midlands.西米德兰兹郡的抗肿瘤坏死因子治疗
Rheumatology (Oxford). 2004 Mar;43(3):400; author reply 400-1. doi: 10.1093/rheumatology/keh042.
6
Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?与依那西普治疗失败的类风湿关节炎患者相比，初治的类风湿关节炎患者对英夫利昔单抗的反应更好吗？
Ann Rheum Dis. 2004 May;63(5):607-8; author reply 608.
7
The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.英夫利昔单抗和依那西普治疗类风湿关节炎的有效性：一项系统评价与经济学评估
Health Technol Assess. 2002;6(21):1-110. doi: 10.3310/hta6210.
8
Maintaining and optimising anti-TNF therapy.维持和优化抗TNF治疗。
Musculoskeletal Care. 2007 Dec;5 Suppl 1:1-17. doi: 10.1002/msc.123.
9
Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database.使用英夫利昔单抗或依那西普治疗的类风湿关节炎患者缓解率低但药物生存期长：来自丹麦全国性DANBIO数据库的结果
Scand J Rheumatol. 2007 Mar-Apr;36(2):151-4. doi: 10.1080/03009740601089267.
10
Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.评估类风湿性关节炎治疗方案的价值：肿瘤坏死因子抑制剂的潜在影响。
Manag Care Interface. 2003 Mar;16(3):44-50, 55.
Zotero 插件